Granules India recalls one batch of Naproxen Sodium 220mg tablets
One batch has 11.4 million units of Naproxen tablets out of which 0.9 million units that were released into the market were recalled
One batch has 11.4 million units of Naproxen tablets out of which 0.9 million units that were released into the market were recalled
This clinical study demonstrated that the 14-day regimen of ImmunoSEB and ProbioSEB CSC3 resolved post-Covid-19 fatigue symptoms and improved patients' functional status and quality of life
Everest gains access to a clinically validated mRNA platform and a potentially “best-in-class” mRNA COVID-19 vaccine with full technology transfer
Extension of hypericin orphan designation beyond cutaneous T-cell lymphoma
The platform revolutionizes how providers deliver financial services by radically simplifying the patient financial experience
The drug will be manufactured at the group's formulation manufacturing facility at the SEZ, Ahmedabad.
Over 70 per cent of the world’s population have no access to MRI scanners and the situation is not that encouraging in India where there are only 0.4 MRI scanners per thousand people
The company plans to enter the formulation business in January 2022. It has also opened a branch in Hyderabad to trade pharmaceutical chemicals
Nipah virus (NiV) is an emerging zoonotic disease that causes severe disease in humans. Signs and symptoms range from asymptomatic to acute respiratory infection and fatal encephalitis
The panel is headed by DCGI Dr VG Somani with representatives from various state drug regulators and health ministry
Subscribe To Our Newsletter & Stay Updated